the Efficacy and Safety of Probiotics eN-Lac® Capsules of Children With Perennial Allergic Rhinitis

Clinical trial NCT01116778 · COMPLETED

Trial details

NCT number: NCT01116778
Sponsor: GenMont Biotech Incorporation
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Perennial Allergic Rhinitis Probiotics Lactobacillus Paracasei GMNL-32 (eN-Lac®)

Start date: 2010-05-01
Primary completion: 2012-01-01
Enrollment: 236

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.